Wim Vandenberghe
Overview
Explore the profile of Wim Vandenberghe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
7189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goris M, Ginis P, Hansen C, Schlenstedt C, Hausdorff J, DCruz N, et al.
Front Neurol
. 2025 Jan;
15():1508800.
PMID: 39845938
Introduction: Freezing of gait (FOG) is a disabling symptom for people with Parkinson's disease (PwPD). Turning on the spot for one minute in alternating directions (360 turn) while performing a...
2.
de Boer E, de Vries B, Van Hecke W, Muhlebner A, Vincken K, Mol C, et al.
J Neurol
. 2024 Dec;
272(1):46.
PMID: 39666071
Background: Primary lateral sclerosis (PLS) is a rare motor neuron disease characterized by upper motor neuron degeneration, diagnosed clinically due to the absence of a (neuropathological) gold standard. Post-mortem studies,...
3.
Westenberger A, Skrahina V, Usnich T, Beetz C, Vollstedt E, Laabs B, et al.
Brain
. 2024 Aug;
147(8):2652-2667.
PMID: 39087914
Estimates of the spectrum and frequency of pathogenic variants in Parkinson's disease (PD) in different populations are currently limited and biased. Furthermore, although therapeutic modification of several genetic targets has...
4.
Van Bogaert T, Boogers A, Peeters J, Vandenberghe W, De Vloo P, Nuttin B, et al.
Brain Stimul
. 2024 Jul;
17(4):813-815.
PMID: 38997104
No abstract available.
5.
Peeters J, Van Bogaert T, Boogers A, Gransier R, Wouters J, De Vloo P, et al.
Brain Stimul
. 2024 May;
17(4):794-801.
PMID: 38821395
Background: Subthalamic deep brain stimulation (STN-DBS) is a well-established therapy to treat Parkinson's disease (PD). However, the STN-DBS sub-target remains debated. Recently, a white matter tract termed the hyperdirect pathway...
6.
Hobbs N, Papoutsi M, Delva A, Kinnunen K, Nakajima M, Van Laere K, et al.
J Huntingtons Dis
. 2024 May;
13(2):163-199.
PMID: 38788082
Neuroimaging is increasingly being included in clinical trials of Huntington's disease (HD) for a wide range of purposes from participant selection and safety monitoring, through to demonstration of disease modification....
7.
Kinnart I, Manders L, Heyninck T, Imberechts D, Praschberger R, Schoovaerts N, et al.
NPJ Parkinsons Dis
. 2024 Apr;
10(1):80.
PMID: 38594264
The pathogenic effect of SNCA gene multiplications indicates that elevation of wild-type α-synuclein levels is sufficient to cause Parkinson's disease (PD). Mitochondria have been proposed to be a major target...
8.
Menon P, Sambin S, Criniere-Boizet B, Courtin T, Tesson C, Casse F, et al.
NPJ Parkinsons Dis
. 2024 Mar;
10(1):72.
PMID: 38553467
Bi-allelic pathogenic variants in PRKN are the most common cause of autosomal recessive Parkinson's disease (PD). 647 patients with PRKN-PD were included in this international study. The pathogenic variants present...
9.
Vercammen J, Terryn J, Van Daele S, Vermeer S, Vandenberghe W
Mov Disord Clin Pract
. 2024 Mar;
11(6):738-741.
PMID: 38454250
No abstract available.
10.
Smeets S, Boogers A, Van Bogaert T, Peeters J, McLaughlin M, Nuttin B, et al.
Brain Stimul
. 2023 Dec;
17(1):71-82.
PMID: 38160999
Background: To maximize clinical benefit and minimize stimulation-induced side effects, optimising deep brain stimulation (DBS) parameters is paramount. Recent literature suggests a potential benefit of short pulse width DBS (spDBS;...